Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
News Release
Enlyte’s 2025 Trends Report Examines ‘The Year of Generative AI’
Industry leaders discuss impact on the growing utilization of gen AI and data analytics as well as strategies addressing clinical and auto cha
Workers' Comp
Article
Specialty Solutions Spotlight: How Bone Growth Stimulators Accelerate Healing
Who is best suited to use a bone growth stimulator after an injury?Recovering from a broken bone can be a long and difficult journey, ofte
Workers' Comp
Article
Functional Capacity Evaluation (FCE) Frequently Asked Questions
What is a Functional Capacity Evaluation (FCE)?An FCE is a comprehensive assessment used to determine an individual's physical
Workers' Comp
Case Study
Clinical Oversight Reduces Claim Costs by Recommending Discharge Over Added PT
Workers' Comp
Article
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs.
Workers' Comp
Podcast